Global Deferasirox Market Growth 2023-2029

Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias.

Deferasirox is marketed as Exjade, Desirox, Defrijet, Desifer, and Jadenu.

The half-life of deferasirox is between 8 and 16 hours allowing once a day dosing. Two molecules of deferasirox are capable of binding to 1 atom of iron which is subsequently eliminated by fecal excretion. Its low molecular weight and high lipophilicity allows the drug to be taken orally unlike deferoxamine which has to be administered by IV route (intravenous infusion). Together with deferiprone, deferasirox seems to be capable of removing iron from cells (cardiac myocytes and hepatocytes) as well as removing iron from the blood.

LPI (LP Information)' newest research report, the “Deferasirox Industry Forecast” looks at past sales and reviews total world Deferasirox sales in 2022, providing a comprehensive analysis by region and market sector of projected Deferasirox sales for 2023 through 2029. With Deferasirox sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Deferasirox industry.

This Insight Report provides a comprehensive analysis of the global Deferasirox landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Deferasirox portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Deferasirox market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Deferasirox and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Deferasirox.

The global Deferasirox market size is projected to grow from US$ 2670.4 million in 2022 to US$ 3675.2 million in 2029; it is expected to grow at a CAGR of 3675.2 from 2023 to 2029.

The major global manufacturers of Dillaros are Novartis, Cipla, Natco Pharma and Sun Pharma, among which Novartis is the industry leader with a market share of around 99%. North America is the largest spending region, with 30 per cent of the market, followed by Europe with 25 per cent.

This report presents a comprehensive overview, market shares, and growth opportunities of Deferasirox market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    500 mg/Tablet
    250 mg/Tablet
    125 mg/Tablet
    Others

Segmentation by application
    Transfusional Iron Overload
    NTDT Caused Iron Overload

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Novartis
    Cipla
    Natco Pharma
    Sun Pharma

Key Questions Addressed in this Report
What is the 10-year outlook for the global Deferasirox market?
What factors are driving Deferasirox market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Deferasirox market opportunities vary by end market size?
How does Deferasirox break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

List of Tables
    Table 1. Deferasirox Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
    Table 2. Deferasirox Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
    Table 3. Major Players of 500 mg/Tablet
    Table 4. Major Players of 250 mg/Tablet
    Table 5. Major Players of 125 mg/Tablet
    Table 6. Major Players of Others
    Table 7. Global Deferasirox Sales by Type (2018-2023) & (M Tablets)
    Table 8. Global Deferasirox Sales Market Share by Type (2018-2023)
    Table 9. Global Deferasirox Revenue by Type (2018-2023) & ($ million)
    Table 10. Global Deferasirox Revenue Market Share by Type (2018-2023)
    Table 11. Global Deferasirox Sale Price by Type (2018-2023) & (USD/Tablet)
    Table 12. Global Deferasirox Sales by Application (2018-2023) & (M Tablets)
    Table 13. Global Deferasirox Sales Market Share by Application (2018-2023)
    Table 14. Global Deferasirox Revenue by Application (2018-2023)
    Table 15. Global Deferasirox Revenue Market Share by Application (2018-2023)
    Table 16. Global Deferasirox Sale Price by Application (2018-2023) & (USD/Tablet)
    Table 17. Global Deferasirox Sales by Company (2018-2023) & (M Tablets)
    Table 18. Global Deferasirox Sales Market Share by Company (2018-2023)
    Table 19. Global Deferasirox Revenue by Company (2018-2023) ($ Millions)
    Table 20. Global Deferasirox Revenue Market Share by Company (2018-2023)
    Table 21. Global Deferasirox Sale Price by Company (2018-2023) & (USD/Tablet)
    Table 22. Key Manufacturers Deferasirox Producing Area Distribution and Sales Area
    Table 23. Players Deferasirox Products Offered
    Table 24. Deferasirox Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    Table 25. New Products and Potential Entrants
    Table 26. Mergers & Acquisitions, Expansion
    Table 27. Global Deferasirox Sales by Geographic Region (2018-2023) & (M Tablets)
    Table 28. Global Deferasirox Sales Market Share Geographic Region (2018-2023)
    Table 29. Global Deferasirox Revenue by Geographic Region (2018-2023) & ($ millions)
    Table 30. Global Deferasirox Revenue Market Share by Geographic Region (2018-2023)
    Table 31. Global Deferasirox Sales by Country/Region (2018-2023) & (M Tablets)
    Table 32. Global Deferasirox Sales Market Share by Country/Region (2018-2023)
    Table 33. Global Deferasirox Revenue by Country/Region (2018-2023) & ($ millions)
    Table 34. Global Deferasirox Revenue Market Share by Country/Region (2018-2023)
    Table 35. Americas Deferasirox Sales by Country (2018-2023) & (M Tablets)
    Table 36. Americas Deferasirox Sales Market Share by Country (2018-2023)
    Table 37. Americas Deferasirox Revenue by Country (2018-2023) & ($ Millions)
    Table 38. Americas Deferasirox Revenue Market Share by Country (2018-2023)
    Table 39. Americas Deferasirox Sales by Type (2018-2023) & (M Tablets)
    Table 40. Americas Deferasirox Sales by Application (2018-2023) & (M Tablets)
    Table 41. APAC Deferasirox Sales by Region (2018-2023) & (M Tablets)
    Table 42. APAC Deferasirox Sales Market Share by Region (2018-2023)
    Table 43. APAC Deferasirox Revenue by Region (2018-2023) & ($ Millions)
    Table 44. APAC Deferasirox Revenue Market Share by Region (2018-2023)
    Table 45. APAC Deferasirox Sales by Type (2018-2023) & (M Tablets)
    Table 46. APAC Deferasirox Sales by Application (2018-2023) & (M Tablets)
    Table 47. Europe Deferasirox Sales by Country (2018-2023) & (M Tablets)
    Table 48. Europe Deferasirox Sales Market Share by Country (2018-2023)
    Table 49. Europe Deferasirox Revenue by Country (2018-2023) & ($ Millions)
    Table 50. Europe Deferasirox Revenue Market Share by Country (2018-2023)
    Table 51. Europe Deferasirox Sales by Type (2018-2023) & (M Tablets)
    Table 52. Europe Deferasirox Sales by Application (2018-2023) & (M Tablets)
    Table 53. Middle East & Africa Deferasirox Sales by Country (2018-2023) & (M Tablets)
    Table 54. Middle East & Africa Deferasirox Sales Market Share by Country (2018-2023)
    Table 55. Middle East & Africa Deferasirox Revenue by Country (2018-2023) & ($ Millions)
    Table 56. Middle East & Africa Deferasirox Revenue Market Share by Country (2018-2023)
    Table 57. Middle East & Africa Deferasirox Sales by Type (2018-2023) & (M Tablets)
    Table 58. Middle East & Africa Deferasirox Sales by Application (2018-2023) & (M Tablets)
    Table 59. Key Market Drivers & Growth Opportunities of Deferasirox
    Table 60. Key Market Challenges & Risks of Deferasirox
    Table 61. Key Industry Trends of Deferasirox
    Table 62. Deferasirox Raw Material
    Table 63. Key Suppliers of Raw Materials
    Table 64. Deferasirox Distributors List
    Table 65. Deferasirox Customer List
    Table 66. Global Deferasirox Sales Forecast by Region (2024-2029) & (M Tablets)
    Table 67. Global Deferasirox Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 68. Americas Deferasirox Sales Forecast by Country (2024-2029) & (M Tablets)
    Table 69. Americas Deferasirox Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 70. APAC Deferasirox Sales Forecast by Region (2024-2029) & (M Tablets)
    Table 71. APAC Deferasirox Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 72. Europe Deferasirox Sales Forecast by Country (2024-2029) & (M Tablets)
    Table 73. Europe Deferasirox Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 74. Middle East & Africa Deferasirox Sales Forecast by Country (2024-2029) & (M Tablets)
    Table 75. Middle East & Africa Deferasirox Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 76. Global Deferasirox Sales Forecast by Type (2024-2029) & (M Tablets)
    Table 77. Global Deferasirox Revenue Forecast by Type (2024-2029) & ($ Millions)
    Table 78. Global Deferasirox Sales Forecast by Application (2024-2029) & (M Tablets)
    Table 79. Global Deferasirox Revenue Forecast by Application (2024-2029) & ($ Millions)
    Table 80. Novartis Basic Information, Deferasirox Manufacturing Base, Sales Area and Its Competitors
    Table 81. Novartis Deferasirox Product Portfolios and Specifications
    Table 82. Novartis Deferasirox Sales (M Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2018-2023)
    Table 83. Novartis Main Business
    Table 84. Novartis Latest Developments
    Table 85. Cipla Basic Information, Deferasirox Manufacturing Base, Sales Area and Its Competitors
    Table 86. Cipla Deferasirox Product Portfolios and Specifications
    Table 87. Cipla Deferasirox Sales (M Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2018-2023)
    Table 88. Cipla Main Business
    Table 89. Cipla Latest Developments
    Table 90. Natco Pharma Basic Information, Deferasirox Manufacturing Base, Sales Area and Its Competitors
    Table 91. Natco Pharma Deferasirox Product Portfolios and Specifications
    Table 92. Natco Pharma Deferasirox Sales (M Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2018-2023)
    Table 93. Natco Pharma Main Business
    Table 94. Natco Pharma Latest Developments
    Table 95. Sun Pharma Basic Information, Deferasirox Manufacturing Base, Sales Area and Its Competitors
    Table 96. Sun Pharma Deferasirox Product Portfolios and Specifications
    Table 97. Sun Pharma Deferasirox Sales (M Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2018-2023)
    Table 98. Sun Pharma Main Business
    Table 99. Sun Pharma Latest Developments
List of Figures
    Figure 1. Picture of Deferasirox
    Figure 2. Deferasirox Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Deferasirox Sales Growth Rate 2018-2029 (M Tablets)
    Figure 7. Global Deferasirox Revenue Growth Rate 2018-2029 ($ Millions)
    Figure 8. Deferasirox Sales by Region (2018, 2022 & 2029) & ($ Millions)
    Figure 9. Product Picture of 500 mg/Tablet
    Figure 10. Product Picture of 250 mg/Tablet
    Figure 11. Product Picture of 125 mg/Tablet
    Figure 12. Product Picture of Others
    Figure 13. Global Deferasirox Sales Market Share by Type in 2022
    Figure 14. Global Deferasirox Revenue Market Share by Type (2018-2023)
    Figure 15. Deferasirox Consumed in Transfusional Iron Overload
    Figure 16. Global Deferasirox Market: Transfusional Iron Overload (2018-2023) & (M Tablets)
    Figure 17. Deferasirox Consumed in NTDT Caused Iron Overload
    Figure 18. Global Deferasirox Market: NTDT Caused Iron Overload (2018-2023) & (M Tablets)
    Figure 19. Global Deferasirox Sales Market Share by Application (2022)
    Figure 20. Global Deferasirox Revenue Market Share by Application in 2022
    Figure 21. Deferasirox Sales Market by Company in 2022 (M Tablets)
    Figure 22. Global Deferasirox Sales Market Share by Company in 2022
    Figure 23. Deferasirox Revenue Market by Company in 2022 ($ Million)
    Figure 24. Global Deferasirox Revenue Market Share by Company in 2022
    Figure 25. Global Deferasirox Sales Market Share by Geographic Region (2018-2023)
    Figure 26. Global Deferasirox Revenue Market Share by Geographic Region in 2022
    Figure 27. Americas Deferasirox Sales 2018-2023 (M Tablets)
    Figure 28. Americas Deferasirox Revenue 2018-2023 ($ Millions)
    Figure 29. APAC Deferasirox Sales 2018-2023 (M Tablets)
    Figure 30. APAC Deferasirox Revenue 2018-2023 ($ Millions)
    Figure 31. Europe Deferasirox Sales 2018-2023 (M Tablets)
    Figure 32. Europe Deferasirox Revenue 2018-2023 ($ Millions)
    Figure 33. Middle East & Africa Deferasirox Sales 2018-2023 (M Tablets)
    Figure 34. Middle East & Africa Deferasirox Revenue 2018-2023 ($ Millions)
    Figure 35. Americas Deferasirox Sales Market Share by Country in 2022
    Figure 36. Americas Deferasirox Revenue Market Share by Country in 2022
    Figure 37. Americas Deferasirox Sales Market Share by Type (2018-2023)
    Figure 38. Americas Deferasirox Sales Market Share by Application (2018-2023)
    Figure 39. United States Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 40. Canada Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 41. Mexico Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 42. Brazil Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 43. APAC Deferasirox Sales Market Share by Region in 2022
    Figure 44. APAC Deferasirox Revenue Market Share by Regions in 2022
    Figure 45. APAC Deferasirox Sales Market Share by Type (2018-2023)
    Figure 46. APAC Deferasirox Sales Market Share by Application (2018-2023)
    Figure 47. China Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 48. Japan Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 49. South Korea Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 50. Southeast Asia Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 51. India Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 52. Australia Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 53. China Taiwan Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 54. Europe Deferasirox Sales Market Share by Country in 2022
    Figure 55. Europe Deferasirox Revenue Market Share by Country in 2022
    Figure 56. Europe Deferasirox Sales Market Share by Type (2018-2023)
    Figure 57. Europe Deferasirox Sales Market Share by Application (2018-2023)
    Figure 58. Germany Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 59. France Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 60. UK Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 61. Italy Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 62. Russia Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 63. Middle East & Africa Deferasirox Sales Market Share by Country in 2022
    Figure 64. Middle East & Africa Deferasirox Revenue Market Share by Country in 2022
    Figure 65. Middle East & Africa Deferasirox Sales Market Share by Type (2018-2023)
    Figure 66. Middle East & Africa Deferasirox Sales Market Share by Application (2018-2023)
    Figure 67. Egypt Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 68. South Africa Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 69. Israel Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 70. Turkey Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 71. GCC Country Deferasirox Revenue Growth 2018-2023 ($ Millions)
    Figure 72. Manufacturing Cost Structure Analysis of Deferasirox in 2022
    Figure 73. Manufacturing Process Analysis of Deferasirox
    Figure 74. Industry Chain Structure of Deferasirox
    Figure 75. Channels of Distribution
    Figure 76. Global Deferasirox Sales Market Forecast by Region (2024-2029)
    Figure 77. Global Deferasirox Revenue Market Share Forecast by Region (2024-2029)
    Figure 78. Global Deferasirox Sales Market Share Forecast by Type (2024-2029)
    Figure 79. Global Deferasirox Revenue Market Share Forecast by Type (2024-2029)
    Figure 80. Global Deferasirox Sales Market Share Forecast by Application (2024-2029)
    Figure 81. Global Deferasirox Revenue Market Share Forecast by Application (2024-2029)

Novartis
Cipla
Natco Pharma
Sun Pharma

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape